First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383
Clinical trial NCT05429723 · UNKNOWN
Trial details
- NCT number
- NCT05429723
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2022-06-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.